Semaglutide 20Mg
Semaglutide is an injectable GLP-1 (glucagon-like peptide-1) receptor agonist, best known for clinically significant weight loss, improved blood sugar, and appetite suppression. Widely used in medical and research settings, it promotes satiety, slows gastric emptying, and supports sustainable reduction in body weight. Semaglutide is FDA approved under the brands Ozempic® (diabetes) and Wegovy® (weight loss), but is also available in compounded research vials for off-label use.
Product Usage: For Research Use Only – Not for Human or Veterinary Use
This product is not a drug, food, cosmetic, or dietary supplement and has not been evaluated or approved by the FDA. It is strictly intended for in vitro laboratory research by qualified professionals. Any use in humans or animals is expressly prohibited and may violate federal, state, or local regulations, including the Federal Food, Drug, and Cosmetic Act. No therapeutic or diagnostic applications are implied or authorized. The purchaser assumes full responsibility for compliance with all applicable laws. By purchasing this product, the buyer represents and warrants that it will be used exclusively for in vitro research and acknowledges that AION PEPTIDES enforces strict internal policies to ensure all sales remain designated for research use only.
Product Name:
Semaglutide
Chemical Information:
Chemical Name: GLP-1 analog peptide
Molecular Formula: C187H291N45O59
Molecular Weight: ~4113.6 Da
Compound Class: GLP-1 receptor agonist
Molecular Structure:
Description:
Long-acting incretin mimetic engineered for metabolic pathway studies.
Research Applications:
- Glucose metabolism research
- Appetite regulation studies
- Obesity models
Storage and Handling:
Store at -20°C.
Product Specifications:
Purity: ≥99% (HPLC Certified)
Appearance: White powder
Solubility: Water soluble
